Which Factors Are Associated With Comorbid Psychiatric Conditions in Patients Affected by Substance Use Disorders? The Impact of COVID-19 Pandemic on Dual-Diagnosis Subjects.

IF 1.5 4区医学 Q3 PSYCHIATRY

Journal of Dual Diagnosis Pub Date : 2024-07-01 Epub Date: 2024-05-10 DOI:10.1080/15504263.2024.2346519

Ilaria Tagliabue, Alice Caldiroli, Enrico Capuzzi, Riccardo Borgonovo, Alberto Scalia, Alessandro Ferrè, Matteo Sibilla, Marco Turco, Letizia M Affaticati, Giovanna Crespi, Giovanni Galimberti, Antonios Dakanalis, Fabrizia Colmegna, Massimiliano Buoli, Massimo Clerici

{"title":"Which Factors Are Associated With Comorbid Psychiatric Conditions in Patients Affected by Substance Use Disorders? The Impact of COVID-19 Pandemic on Dual-Diagnosis Subjects.","authors":"Ilaria Tagliabue, Alice Caldiroli, Enrico Capuzzi, Riccardo Borgonovo, Alberto Scalia, Alessandro Ferrè, Matteo Sibilla, Marco Turco, Letizia M Affaticati, Giovanna Crespi, Giovanni Galimberti, Antonios Dakanalis, Fabrizia Colmegna, Massimiliano Buoli, Massimo Clerici","doi":"10.1080/15504263.2024.2346519","DOIUrl":null,"url":null,"abstract":"Objective: To investigate demographic/cinical variables associated to dual diagnosis and the psychological reaction of dual-diagnosis patients to COVID-19 pandemic.Methods: Information was collected at the Addiction Service of Monza, Italy. The Impact of Event Scale-Revised (IES-R), a self-report questionnaire measuring the subjective response to a traumatic event, was administered. Univariate analyses and binary logistic regression were performed. IES-R scores were compared between groups defined by qualitative variables through one-way analyses of variance (ANOVA).Results: 118 outpatients were included, 48.3% with dual diagnosis. Alcohol use disorder and being female were associated to dual diagnosis. IES-R scores were significantly higher in the dual-diagnosis group, especially for personality disorders (PDs). IES-R scores were higher in patients taking treatment for substance use disorder (SUD).Conclusions: Females and alcohol abusers were at-risk subjects for dual diagnosis. Patients with SUD and PDs may benefit from additional support, especially when traumatic life events occur.Trial registration: ClinicalTrials.gov Identifier: NCT04694482.","PeriodicalId":46571,"journal":{"name":"Journal of Dual Diagnosis","volume":" ","pages":"201-209"},"PeriodicalIF":1.5000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Dual Diagnosis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/15504263.2024.2346519","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/10 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PSYCHIATRY","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: To investigate demographic/cinical variables associated to dual diagnosis and the psychological reaction of dual-diagnosis patients to COVID-19 pandemic.

Methods: Information was collected at the Addiction Service of Monza, Italy. The Impact of Event Scale-Revised (IES-R), a self-report questionnaire measuring the subjective response to a traumatic event, was administered. Univariate analyses and binary logistic regression were performed. IES-R scores were compared between groups defined by qualitative variables through one-way analyses of variance (ANOVA).

Results: 118 outpatients were included, 48.3% with dual diagnosis. Alcohol use disorder and being female were associated to dual diagnosis. IES-R scores were significantly higher in the dual-diagnosis group, especially for personality disorders (PDs). IES-R scores were higher in patients taking treatment for substance use disorder (SUD).

Conclusions: Females and alcohol abusers were at-risk subjects for dual diagnosis. Patients with SUD and PDs may benefit from additional support, especially when traumatic life events occur.

Trial registration: ClinicalTrials.gov Identifier: NCT04694482.

查看原文本刊更多论文

哪些因素与受药物使用障碍影响的患者合并精神疾病有关？COVID-19大流行对双重诊断对象的影响。

目的调查与双重诊断相关的人口统计学/临床变量，以及双重诊断患者对 COVID-19 大流行的心理反应。研究方法在意大利蒙扎戒毒服务机构收集信息。采用了事件影响量表修订版（IES-R），这是一份自我报告问卷，用于测量对创伤事件的主观反应。进行了单变量分析和二元逻辑回归。通过单因素方差分析（ANOVA）比较了由定性变量定义的各组之间的 IES-R 分数。结果：共纳入 118 名门诊患者，其中 48.3% 有双重诊断。酒精使用障碍和女性与双重诊断有关。双重诊断组的 IES-R 评分明显较高，尤其是人格障碍 (PD)。接受药物使用障碍（SUD）治疗的患者的 IES-R 得分更高。结论女性和酗酒者是双重诊断的高危人群。SUD 和 PD 患者可能会从额外的支持中受益，尤其是在发生创伤性生活事件时。试验注册：ClinicalTrials.gov Identifier：NCT04694482。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Dual Diagnosis Multiple-

CiteScore

4.90

自引率

13.60%

发文量

期刊介绍： Journal of Dual Diagnosis is a quarterly, international publication that focuses on the full spectrum of complexities regarding dual diagnosis. The co-occurrence of mental health and substance use disorders, or “dual diagnosis,” is one of the quintessential issues in behavioral health. Why do such high rates of co-occurrence exist? What does it tell us about risk profiles? How do these linked disorders affect people, their families, and the communities in which they live? What are the natural paths to recovery? What specific treatments are most helpful and how can new ones be developed? How can we enhance the implementation of evidence-based practices at clinical, administrative, and policy levels? How can we help clients to learn active recovery skills and adopt needed supports, clinicians to master new interventions, programs to implement effective services, and communities to foster healthy adjustment? The Journal addresses each of these perplexing challenges.